5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | NEUTRAL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.58▲ | 3.53▲ | 3.53▲ | 3.49▲ | 3.87▼ |
MA10 | 3.51▲ | 3.52▲ | 3.57▲ | 3.71▼ | 3.65▼ |
MA20 | 3.79▼ | 3.86▼ | 3.86▼ | 3.81▼ | 3.51▲ |
MA50 | 3.91▼ | 3.92▼ | 3.87▼ | 3.58▲ | 4.17▼ |
MA100 | 3.81▼ | 3.63▼ | 3.60▲ | 3.44▲ | 4.21▼ |
MA200 | 3.50▲ | 3.52▲ | 3.47▲ | 3.79▼ | 25.01▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.009▼ | -0.029▼ | -0.040▼ | -0.063▼ | 0.097▲ |
RSI | 44.242▼ | 44.679▼ | 44.563▼ | 47.252▼ | 48.463▼ |
STOCH | 65.675 | 42.604 | 37.470 | 13.808▼ | 48.888 |
WILL %R | -55.556 | -64.103 | -67.816 | -78.844▼ | -61.818 |
CCI | 15.238 | -16.902 | -33.078 | -78.723 | 1.911 |
Thursday, February 06, 2025 06:00 AM
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) has announced significant advancements in its intellectual property portfolio, reinforcing the company’s leadership in the development of DNA ...
|
Wednesday, February 05, 2025 09:55 AM
Currently, APRE is trading at $4.33 up by 8.91% The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the ...
|
Wednesday, February 05, 2025 06:12 AM
DOYLESTOWN, Pa. - Aprea Therapeutics, Inc. (NASDAQ: NASDAQ:APRE), a biopharmaceutical company with a market capitalization of $21.2 million focused on developing treatments targeting cancer cell ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
14/02/25 | 3.44 | 3.64 | 3.3698 | 3.5856 | 7,796 |
13/02/25 | 3.47 | 3.5596 | 3.4128 | 3.53 | 7,383 |
12/02/25 | 3.40 | 3.47 | 3.30 | 3.43 | 8,495 |
11/02/25 | 3.49 | 3.50 | 3.31 | 3.31 | 29,363 |
10/02/25 | 3.88 | 3.88 | 3.4501 | 3.59 | 40,871 |
07/02/25 | 3.87 | 4.1002 | 3.75 | 3.83 | 22,987 |
06/02/25 | 4.31 | 4.31 | 3.71 | 3.975 | 35,577 |
05/02/25 | 4.21 | 4.65 | 4.057 | 4.057 | 160,758 |
04/02/25 | 3.915 | 4.02 | 3.812 | 3.90 | 37,193 |
03/02/25 | 3.71 | 3.87 | 3.71 | 3.85 | 13,714 |
|
|
||||
|
|
||||
|
|